Share on StockTwits
 

Research analysts at Scotiabank upped their target price on shares of Walgreens (NYSE: WAG) from $47.00 to $50.00 in a report released on Wednesday.

Walgreens (NYSE: WAG) traded down 0.14% on Wednesday, hitting $45.955. Walgreens has a 52-week low of $28.53 and a 52-week high of $46.33. The stock’s 50-day moving average is currently $41.48. The company has a market cap of $43.432 billion and a price-to-earnings ratio of 20.82.

Walgreens (NYSE: WAG) last announced its earnings results on Tuesday, March 19th. The company reported $0.96 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.94 by $0.02. The company had revenue of $18.65 billion for the quarter, compared to the consensus estimate of $18.72 billion. During the same quarter in the previous year, the company posted $0.78 earnings per share. The company’s revenue for the quarter was up .0% on a year-over-year basis. On average, analysts predict that Walgreens will post $3.27 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Guggenheim raised their price target on shares of Walgreens to $50.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Walgreens in a research note to investors on Wednesday. They now have a $47.00 price target on the stock. Finally, analysts at Morgan Stanley reiterated an “equal weight” rating on shares of Walgreens in a research note to investors on Wednesday.

One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $49.13.

Walgreen Co (NYSE: WAG), together with its subsidiaries, operates the drugstore chain in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.